Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ALDXthis companyAldeyra The	$0.62	-9.25×	7.03×	0×	-8.1×	40.2%	0.0%	0.0%	0.0%	-76.5%	-59.0%	-10.7%	0.35×	1.72×	-18.51×	2.58×	0.0%	1	-15.37	3	B
ANROAlto Neuroscience, Inc.	$27.80	-8.13×	3.4×	0×	-5.68×	-79.1%	0.0%	0.0%	0.0%	-41.8%	-38.2%	-10.1%	0.03×	2.86×	-26.88×	15.69×	0.0%	2	15.63	2	C+
CADLCandel Therapeutics, Inc.	$9.49	-7.85×	5.76×	0×	-5.15×	-76.1%	0.0%	0.0%	0.0%	-73.5%	-41.4%	-13.0%	0.04×	3.35×	-22.78×	13.31×	0.0%	2	3.11	1	C-
CTNMContineum Therapeutics, Inc.	$10.30	-5.27×	1.21×	0×	-3.68×	-76.3%	0.0%	0.0%	0.0%	-23.0%	-25.3%	-17.5%	0.03×	0.99×	0×	27.5×	0.0%	2	17.28	2	C+
GNLXGenelux Corporation	$2.07	-5.07×	14.04×	20,261.21×	-5.02×	-100.5%	-7075.0%	-415175.0%	-401812.5%	-278.5%	-251.1%	-16.3%	0.15×	0.12×	0×	2.43×	0.0%	2	-14.51	1	C-
KYTXKyverna Therapeutics, Inc.	$5.17	-2.58×	1.79×	0×	-2.02×	-60.3%	0.0%	0.0%	0.0%	-69.4%	-65.0%	-36.9%	0.12×	0.6×	-347.29×	7.75×	0.0%	1	-1.13	2	C
Peer median	—	-5.27×	3.4×	0×	-5.02×	-76.3%	0.0%	0.0%	0.0%	-69.4%	-41.4%	-16.3%	0.04×	0.99×	-22.78×	13.31×	0.0%	2	3.11	2	—